Radioactive iodine therapy for follicular thyroid cancer: a 15 years follow-up study of Chinese patients.

Purpose: To identify long-term predictors of distant metastases (DM) and the overall survival (OS) of follicular thyroid cancer (FTC) patients who underwent radioactive iodine (RAI) therapy. And to expand the knowledge about the clinical course and experience of RAI treatment for FTC.

Materials: A total of 117 FTC patients who underwent RAI therapy at our institution from 2005 to 2020 were retrospectively studied.